Archive for 2007/09


Studies Suggest Key Correlation Between Lung Cancer Subtype And Treatment Outcomes

In clinical research, patients with advanced non-small cell lung cancer (NSCLC) that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA(R) (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel. The data (ECCO Abstract # 6521)(1) were presented at the 14th European Cancer Conference ECCO) in Barcelona. [click link for full article]
(more...)


Pharmacopeia Earns Milestone Payment From Schering Plough On Initiation Of Phase 1 Clinical Trials Of Novel Therapeutic Candidate

Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced that Schering Plough has initiated a Phase 1 clinical trial in the United States with PS948115, a compound identified from the collaboration between the two companies. The compound is being evaluated as a potential treatment for respiratory disease. [click link for full article]
(more...)


Former UN Messenger Of Peace To Fight Tuberculosis As A Stop TB Ambassador

Anna Cataldi, who served as UN Messenger of Peace from 1998 to 2007, has joined the global fight against tuberculosis (TB). Ms Cataldi, who was appointed as an Ambassador of the Stop TB Partnership, will raise awareness worldwide about the unfair burden of TB on refugees, migrants, people living in poverty and other disadvantaged groups. [click link for full article]
(more...)


New Survey Finds That Smokers Not Flouting The Ban, UK

A new survey has revealed that the vast majority of smokers in England have been complying with the new smoking legislation since its introduction in July. 75 per cent of people said the ban had been good for their health while 97 per cent of adults said they were either not smoking where it is banned or were giving up smoking completely. [click link for full article]
(more...)


Lower Back Pain May Respond Better To Acupuncture Therapy Than Conventional Therapy

If you suffer from lower back pain you might find that six months of acupuncture gives you superior results to conventional therapy, says a report in Archives of Internal Medicine (JAMA/Archives), September 24th issue. However, the study also indicates that sham acupuncture seems to be effective as well. The authors explain "Low back pain is a common, impairing and disabling condition, often long-term, with an estimated lifetime prevalence of 70 percent to 85 percent. [click link for full article]
(more...)


Asthma Hits Black Patients Worse, Not Matter What The Disease Severity Is

Hospitalization or a visit to the emergency department is more likely for black patients with asthma than for white patients, regardless of what the managed care settings are, according to an article published in Archives of Internal Medicine (JAMA/Archives), September 24th issue. As background information, the authors explain that black patients who suffer from asthma have worse control of their symptoms and are more likely to be hospitalized than white patients. [click link for full article]
(more...)


Asthma UK Scotland Welcomes Plans To Raise Legal Age For Buying Tobacco

Gordon Brown, Public Affairs & Communications Manager at Asthma UK Scotland, says: 'We are delighted that the Scottish Government has taken another step forward in tackling the damage tobacco can do. We know that smoking is bad for everyone's health, but this is especially true for people with asthma. [click link for full article]
(more...)


AAKP Announces Annual Award Winners

The American Association of Kidney Patients (AAKP) is pleased to announce the winners of the 2007 Annual Awards. The awards recognize individuals who have made a significant contribution to the kidney community. Nominations were received from across the country from both renal professionals and renal patients, and were presented during the 34th Annual AAKP Convention held in St. Louis, MO. These individuals have shown a great desire to improve the lives of all kidney patients. [click link for full article]
(more...)


FDA Proposing Phase Out Of CFCs In Metered-Dose Inhalers For Epinephrine

The U.S. Food and Drug Administration proposed a change to its regulation on the use of chlorofluorocarbons or CFCs in metered dose inhalers (MDIs) for epinephrine. The rule would remove the "essential-use" designation that allows the use of CFCs in these medical devices. Epinephrine MDIs are used for the temporary relief of occasional symptoms of mild asthma. [click link for full article]
(more...)


Leading Researchers Present Latest Findings In Asthma And Allergy, UK

International scientists and key opinion leaders in asthma and allergy research will be presenting their latest findings at King's College London at a symposium to showcase some of the most current developments in this field. Asthma and Allergy- from mechanisms to biomarkers and therapeutic targets, highlights key areas of research such as airway inflammation and airway structure. [click link for full article]
(more...)